Last year, Pfizer launched a generic version of one of its epilepsy medicines to take some sales from non-branded competition.

ECONOMIST: The best medicine? | The

Gopal Dabade of All India Drug Action Network, an India-based non-profit group that works for access to essential medicines, said the ruling will allow Indian generic manufacturers to continue to supply Indians and consumers in other developing countries with cheap medicines.

WSJ: Novartis Loses Glivec Patent Battle in India